Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan

References

• Mahmood RK, et al.Systematic review: study of the prescribing pattern of antibiotics in outpatients and emergency departments in the Gulf RegionFront Pharmacol202011 10.3389/fphar.2020.585051 33424594 7786364
   PubMed Web of Science ®Google Scholar
• Vaughn VM, et al.The association of antibiotic stewardship with fluoroquinolone prescribing in Michigan hospitals: a multi-hospital cohort studyClin Infect Dis201969812691277 10.1093/cid/ciy1102 30759198 6763628
   PubMed Web of Science ®Google Scholar
• Tamma PD, et al.Association of adverse events with antibiotic use in hospitalized patientsJAMA Intern Med2017177913081315 10.1001/jamainternmed.2017.1938 28604925 5710569
   PubMed Web of Science ®Google Scholar
• Baggs J, et al.Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012JAMA Intern Med20161761116391648 10.1001/jamainternmed.2016.5651 27653796
   PubMed Web of Science ®Google Scholar
• Buehrle DJ, Wagener MM, Clancy CJOutpatient fluoroquinolone prescription fills in the United States, 2014 to 2020: assessing the impact of Food and Drug Administration safety warningsAntimicrob Agents Chemother2021657e00151e221 1:CAS:528:DC%2BB3MXisVKjtL%2FF 10.1128/AAC.00151-21 33875430 8218674
   PubMed Web of Science ®Google Scholar
• Robinson TF, et al.Evaluation of the trends and appropriateness of fluoroquinolone use in the outpatient treatment of acute uncomplicated cystitis at five family practice clinicsJ Clin Pharm Ther2020453513519 1:CAS:528:DC%2BB3cXosVeju7g%3D 10.1111/jcpt.13099 31821580
   PubMed Web of Science ®Google Scholar
• Baggio D, Ananda-Rajah MRFluoroquinolone antibiotics and adverse eventsAust Prescr2021445161164 10.18773/austprescr.2021.035 34728881 8542490
   PubMed Web of Science ®Google Scholar
• Suda KJ, et al.Antibiotic expenditures by medication, class, and healthcare setting in the United States, 2010–2015Clin Infect Dis2018662185190 10.1093/cid/cix773 29020276
   PubMed Web of Science ®Google Scholar
• Kabbani S, et al.Opportunities to improve fluoroquinolone prescribing in the United States for adult ambulatory care visitsClin Infect Dis2018671134136 10.1093/cid/ciy035 29373664 6005119
   PubMed Web of Science ®Google Scholar
• Mallhi TH, et al.Assessment of knowledge regarding safety profile, use, and boxed warnings of fluoroquinolones among healthcare professionals in Saudi Arabia: a potential implication for drug regulatory authoritiesFront Med20229819 10.3389/fmed.2022.816320
   Web of Science ®Google Scholar
• Shehab N, et al.Emergency department visits for antibiotic-associated adverse eventsClin Infect Dis2008476735743 10.1086/591126 18694344
   PubMed Web of Science ®Google Scholar
• Bratsman A, et al.Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warningPharmacoepidemiol Drug Saf2020296701707 10.1002/pds.5018 32390266
   PubMed Web of Science ®Google Scholar
• Yarrington ME, et al.Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitalsInfect Control Hosp Epidemiol2019401112971300 10.1017/ice.2019.247 31474240
   PubMed Web of Science ®Google Scholar
• Ross RK, et al.Outpatient fluoroquinolone use in children, 2000–2018J Pediatr Infect Dis Soc2021105576585 1:CAS:528:DC%2BB3MXhsFGrt7%2FN 10.1093/jpids/piaa156
   PubMed Web of Science ®Google Scholar
• Markley JD, et al.Outpatient fluoroquinolone medication use evaluation at an academic veterans affairs medical centerInfect Control Hosp Epidemiol202041S1s341s342 10.1017/ice.2020.953
   Google Scholar
• Kelly L, et al.Fluoroquinolone use in a rural practiceCan J Rural Med202126114 10.4103/cjrm.cjrm_67_20 33380601
   PubMed Web of Science ®Google Scholar
• Tran PT, et al.Association of US Food and Drug Administration removal of indications for use of oral quinolones with prescribing trendsJAMA Intern Med20211816808816 10.1001/jamainternmed.2021.1154 33871571
   PubMed Web of Science ®Google Scholar
• Lasser KE, et al.Adherence to black box warnings for prescription medications in outpatientsArch Intern Med20061663338344 10.1001/archinte.166.3.338 16476875
   PubMed Web of Science ®Google Scholar
• Klein EY, et al.Global increase and geographic convergence in antibiotic consumption between 2000 and 2015Proc Natl Acad Sci201811515E3463E3470 1:CAS:528:DC%2BC1cXht1Gqt7jM 10.1073/pnas.1717295115 29581252 5899442
   PubMed Web of Science ®Google Scholar
• Sarwar MR, et al.Antimicrobial use by WHO methodology at primary health care centers: a cross sectional study in Punjab, PakistanBMC Infect Dis20181819 10.1186/s12879-018-3407-z
   PubMed Web of Science ®Google Scholar
• Atif M, et al.Investigation of antimicrobial use at a tertiary care hospital in Southern Punjab, Pakistan using WHO methodologyAntimicrob Resist Infect Control20176112 10.1186/s13756-017-0199-7
   Web of Science ®Google Scholar
• Hashmi H, et al.Prescribing patterns for upper respiratory tract infections: a prescription-review of primary care practice in Quetta, Pakistan and the implicationsFront Public Health2021 10.3389/fpubh.2021.787933 34869195 8640527
   PubMed Web of Science ®Google Scholar
• Mallhi TH, et al.Defining acute kidney injury in dengue viral infection by conventional and novel classification systems (AKIN and RIFLE): a comparative analysisPostgrad Med J20169210847886 10.1136/postgradmedj-2015-133582 26729887
   PubMed Web of Science ®Google Scholar
• Hicks LA, et al.US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011Clin Infect Dis201560913081316 25747410
   PubMed Web of Science ®Google Scholar
• Alves C, Mendes D, Marques FBFluoroquinolones and the risk of tendon injury: a systematic review and meta-analysisEur J Clin Pharmacol20197514311443 1:CAS:528:DC%2BC1MXhtlegs73K 10.1007/s00228-019-02713-1 31270563
   PubMed Web of Science ®Google Scholar
• Etminan M, Brophy JM, Samii AOral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic studyNeurology2014831412611263 1:CAS:528:DC%2BC2cXhs12gtb3J 10.1212/WNL.0000000000000846 25150290
   PubMed Web of Science ®Google Scholar
• Aslam A, et al.Self-medication with antibiotics: prevalence, practices and related factors among the Pakistani publicAntibiotics2022116795 1:CAS:528:DC%2BB38XhslChtLfF 10.3390/antibiotics11060795 35740201 9219843
   PubMedGoogle Scholar
• Nazir S, Azim MAssessment of antibiotic self-medication practice among public in the northwestern region of PakistanEur J Hosp Pharm2017244200203 10.1136/ejhpharm-2015-000733 31156941
   PubMedGoogle Scholar
• Smollin CG, Fu J, Levin RRecognition and knowledge of medications with black box warnings among pediatricians and emergency physiciansJ Med Toxicol201612180184 10.1007/s13181-015-0519-3 26553279
   PubMedGoogle Scholar
• Mathews B, et al.Adverse effects of fluoroquinolones: a retrospective cohort study in a South Indian tertiary healthcare facilityAntibiotics201983104 1:CAS:528:DC%2BB3cXltVGgu74%3D 10.3390/antibiotics8030104 31357640 6784165
   PubMed Web of Science ®Google Scholar
• Leone R, et al.Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regionsDrug Saf200326109120 1:CAS:528:DC%2BD3sXhs1yqsbo%3D 10.2165/00002018-200326020-00004 12534327
   PubMed Web of Science ®Google Scholar
• Sankar A, et al.Association of fluoroquinolone prescribing rates with black box warnings from the US food and drug administrationJAMA Netw Open2021412e2136662e2136662 10.1001/jamanetworkopen.2021.36662 34851398 8637256
   PubMed Web of Science ®Google Scholar
• Gorelik E, et al.Fluoroquinolones and cardiovascular risk: a systematic review, meta-analysis and network meta-analysisDrug Saf201942529538 1:CAS:528:DC%2BC1cXitFansL3F 10.1007/s40264-018-0751-2 30368737
   PubMed Web of Science ®Google Scholar
• Kennedy KE, et al.Hypoglycemia associated with antibiotics alone and in combination with sulfonylureas and meglitinides: an epidemiologic surveillance study of the FDA Adverse Event Reporting System (FAERS)Drug Saf202043363369 1:CAS:528:DC%2BC1MXisV2ksbzE 10.1007/s40264-019-00901-7 31863282 7117991
   PubMed Web of Science ®Google Scholar
• Chou H-W, et al.Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in TaiwanClin Infect Dis2013577971980 1:CAS:528:DC%2BC3sXhslaktLjP 10.1093/cid/cit439 23948133
   PubMed Web of Science ®Google Scholar
• Gatti M, et al.Assessing the association between fluoroquinolones and emerging adverse drug reactions raised by regulatory agencies: an umbrella reviewEur J Intern Med2020756070 1:CAS:528:DC%2BB3cXhsFyisb4%3D 10.1016/j.ejim.2020.01.009 31983604
   PubMed Web of Science ®Google Scholar
• Adams M, Clinard V, Rich WKnowledge level and perceptions of pharmacists and prescribers regarding boxed warningsJ Adv Med Pharm Sci20171511
   Google Scholar